A simple, sensitive method for the assay of adenyl cyclase.

PubWeight™: 8.05‹?› | Rank: Top 0.1%

🔗 View Article (PMID 4300679)

Published in J Pharmacol Exp Ther on October 01, 1968

Authors

G Krishna, B Weiss, B B Brodie

Articles citing this

(truncated to the top 100)

Cyclic AMP receptor protein of E. coli: its role in the synthesis of inducible enzymes. Proc Natl Acad Sci U S A (1970) 13.26

Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J Clin Invest (1971) 6.09

Identification of a calcium-binding protein as a calcium-dependent regulator of brain adenylate cyclase. Proc Natl Acad Sci U S A (1975) 3.50

Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. J Clin Invest (1971) 2.61

Glucose and the metabolism of adenosine 3':5'-cyclic monophosphate in Escherichia coli. Proc Natl Acad Sci U S A (1971) 2.46

Cyclic 3',5'-adenosine monophosphate in the human lukocyte: synthesis, degradation, andeffects n neutrophil candidacidal activity. J Clin Invest (1971) 2.35

Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa. J Clin Invest (1974) 2.28

Effect of Escherichia coli on fluid transport across canine small bowel. Mechanism and time-course with enterotoxin and whole bacterial cells. J Clin Invest (1973) 2.25

Stimulated formation of adenosine 3',5'-cyclic phosphate in cerebral cortex: synergism between electrical activity and biogenic amines. Proc Natl Acad Sci U S A (1970) 2.19

Effects of cholera enterotoxin on adenosine 3',5'-monophosphate and neutrophil function. Comparison with other compounds which stimulate leukocyte adenyl cyclase. J Clin Invest (1973) 2.16

Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness. Proc Natl Acad Sci U S A (1976) 2.14

ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase. Proc Natl Acad Sci U S A (1970) 2.09

The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. Biochem J (1971) 2.04

Short communications. Subunit A from cholera toxin is an activator of adenylate cyclase in pigeon erythrocytes. Biochem J (1975) 1.98

Studies on the production of enterotoxins by Bacillus cereus. J Clin Pathol (1976) 1.86

Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Biochem J (1978) 1.85

Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78

Membrane association of a 36,000-dalton substrate for tyrosine phosphorylation in chicken embryo fibroblasts transformed by avian sarcoma viruses. J Cell Biol (1983) 1.65

Inhibition of hormone-sensitive adenyl cyclase by phenothiazines. Proc Natl Acad Sci U S A (1970) 1.58

Myocardial adenyl cyclase: activation by thyroid hormones and evidence for two adenyl cyclase systems. J Clin Invest (1969) 1.56

Role of calcium and adenosine-3':5'-cyclic monophosphate in controlling fly salivary gland secretion. Proc Natl Acad Sci U S A (1972) 1.51

Activation of renal cortical adenylate cyclase by circulating immunoreactive parathyroid hormone fragments. J Clin Invest (1973) 1.47

Localization of the action of cholera toxin on adenyl cyclase in mucosal epithelial cells of rabbit intestine. J Clin Invest (1972) 1.46

Measurements of rates of adenosine 3':5'-cyclic monophosphate synthesis in intact Escherichia coli B. Proc Natl Acad Sci U S A (1973) 1.43

Phosphoenolpyruvate:sugar phosphotransferase system-mediated regulation of carbohydrate metabolism in Salmonella typhimurium. J Bacteriol (1982) 1.42

Importance of the intestinal inflammatory reaction in salmonella-mediated intestinal secretion. Infect Immun (1979) 1.38

Role of Ca2+ and cyclic AMP in the regulation of the production of prostacyclin by the vascular endothelium. Proc Natl Acad Sci U S A (1982) 1.36

Studies on the mode of action of cholera toxin. Effects on solubilized adenylate cyclase. J Clin Invest (1974) 1.34

Cyclic adenosine monophosphate in the nervous system of Aplysia californica. I. Increased synthesis in response to synaptic stimulation. J Gen Physiol (1972) 1.34

Metabolism of bovine parathyroid hormone. Immunological and biological characteristics of fragments generated by liver perfusion. J Clin Invest (1975) 1.30

Adenosine 3',5'-cyclic monophosphate and morphology in Neurospora crassa: drug-induced alterations. J Bacteriol (1975) 1.26

Effects of vasopressin and prostaglandin E 1 on the adenyl cyclase-cyclic 3',5'-adenosine monophosphate system of the renal medulla of the rat. J Clin Invest (1971) 1.26

Biochemically differentiated mouse glial lines carrying a nervous system specific cell surface antigen (NS-1). Proc Natl Acad Sci U S A (1975) 1.24

The effects of thrombin on adenyl cyclase activity and a membrane protein from human platelets. J Clin Invest (1972) 1.24

Na+-K+-activated adenosine triphosphatase and intestinal electrolyte transport. Effect of adrenal steroids. J Clin Invest (1975) 1.22

The effect of sulfonylurea drugs on rabbit myocardial contractility, canine purkinje fiber automaticity, and adenyl cyclase activity from rabbit and human hearts. J Clin Invest (1972) 1.21

Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain. Proc Natl Acad Sci U S A (1974) 1.20

Evidence against an involvement of cyclic nucleotides in the induction of betacyanin synthesis by cytokinins. Biochem J (1975) 1.18

Altered activity of the nucleotide regulatory site in the parathyroid hormone-sensitive adenylate cyclase from the renal cortex of a patient with pseudohypoparathyroidism. J Clin Invest (1978) 1.17

Epinephrine binding to the catecholamine receptor and activation of the adenylate cyclase in erythrocyte membranes (hormone receptor- -adrenergic receptor-cyclic AMP-turkey). Proc Natl Acad Sci U S A (1972) 1.16

beta-adrenergic receptors in rat liver: effects of adrenalectomy. Proc Natl Acad Sci U S A (1976) 1.16

Effects of crp mutations on adenosine 3',5'-monophosphate metabolism in Salmonella typhimurium. J Bacteriol (1976) 1.16

Phosphorylation of animal virus proteins by a virion protein kinase. J Virol (1973) 1.15

Effects of cycloheximide on the response of intestinal mucosa to cholera enterotoxin. J Clin Invest (1973) 1.14

Effects of Ca++ and prostaglandin E1 on vasopressin activation of renal adenyl cyclase. J Clin Invest (1971) 1.14

Hormone-like activity of a thymus humoral factor on the induction of immune competence in lymphoid cells. J Exp Med (1974) 1.14

Immediate and time-dependent effects of glucose on insulin release from rat pancreatic tissue. Evidence for different mechanisms of action. J Clin Invest (1978) 1.13

Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate. Biochem J (1970) 1.13

Effects of catecholamines and their interaction with other hormones on cyclic 3',5'-adenosine monophosphate of the kidney. J Clin Invest (1972) 1.12

The effect upon the liver of evisceration with or without hormone replacement. Surg Gynecol Obstet (1978) 1.11

Endogenous lectins from cultured cells: subcellular localization of carbohydrate-binding protein 35 in 3T3 fibroblasts. J Cell Biol (1986) 1.10

Effects of cholera toxin on adenylate cyclase. Studies with guanylylimidodiphosphate. J Clin Invest (1975) 1.09

Transformation of chick-embryo fibroblasts by wild-type and temperature-sensitive Rous sarcoma virus alters adenylate cyclase activity. Proc Natl Acad Sci U S A (1973) 1.08

Activation of adenylate cyclase by cholera toxin in rat liver homogenates. J Clin Invest (1976) 1.05

Adenosine 3',5'-cyclic monophosphate in Vibrio cholerae. Infect Immun (1975) 1.05

Prevention and reversal of cholera enterotoxin-induced intestinal secretion by methylprednisolone induction of Na+-K+-ATPase. J Clin Invest (1976) 1.04

Association of mouse liver adenosine 3':5'-cyclic monophosphate (cyclic AMP) levels with histocompatibility-2 genotype. Proc Natl Acad Sci U S A (1975) 1.04

Cyclic adenosine 3':5'-monophosphate in moss protonema: a comparison of its levels by protein kinase and gilman assays. Plant Physiol (1977) 1.03

Activation of myocardial adenyl cyclase by histamine in guinea pig, cat, and human heart. J Clin Invest (1971) 1.03

A temperature-sensitive change in the energy of activation of hormone-stimulated hepatic adenylyl cyclase. Proc Natl Acad Sci U S A (1973) 1.01

Effect of prostaglandin E 1 on certain renal actions of parathyroid hormone. J Clin Invest (1972) 1.01

Properties of adenyl cyclase from human jejunal mucosa during naturally acquired cholera and convalescence. J Clin Invest (1972) 1.01

The selective action of beta-adrenoceptor blocking drugs and the nature of beta1 and beta2 adrenoceptors. Br J Pharmacol (1977) 1.00

Cellular localization of the transforming protein of wild-type and temperature-sensitive Fujinami sarcoma virus. J Virol (1984) 0.98

Cyclic AMP metabolism and adenylate cyclase concentration in patients with advanced hepatic cirrhosis. Gastroenterology (1978) 0.98

Lack of relationship between myocardial cyclic AMP concentrations and inotropic effects of sympathomimetic amines. Br J Pharmacol (1971) 0.98

The reaction of glucagon with its receptor: evidence for discrete regions of activity and binding in the glucagon molecule. Proc Natl Acad Sci U S A (1971) 0.97

Chlorpromazine reverses diarrhea in piglets caused by enterotoxigenic Escherichia coli. Infect Immun (1979) 0.96

Stimulation of anterior pituitary adenyl cyclase activity and adenosine 3':5'-cyclic phosphate by hypothalamic extract and prostaglandin E1. Proc Natl Acad Sci U S A (1969) 0.95

Properties of the separated catalytic and regulatory units of brain adenylate cyclase. Proc Natl Acad Sci U S A (1980) 0.95

Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclase. J Clin Invest (1970) 0.94

Evidence for delayed development of the glucagon receptor of adenylate cyclase in the fetal and neonatal rat heart. J Clin Invest (1973) 0.94

Transmissible gastroenteritis. Mechanisms responsible for diarrhea in an acute viral enteritis in piglets. J Clin Invest (1974) 0.94

The stimulatory guanine-nucleotide regulatory unit of adenylate cyclase from bovine cerebral cortex. ADP-ribosylation and purification. Biochem J (1987) 0.94

Direct inhibitory effect of hypercalcemia on renal actions of parathyroid hormone. J Clin Invest (1974) 0.94

Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism. J Clin Invest (1987) 0.94

Secreted adenylate cyclase of Bordetella pertussis: calmodulin requirements and partial purification of two forms. J Bacteriol (1986) 0.93

Decreased myocardial adenyl cyclase activity in hypothyroidism. J Clin Invest (1969) 0.93

Calmodulin stabilization of kinetochore microtubule structure to the effect of nocodazole. J Cell Biol (1988) 0.92

Adenosine 3':5'-cyclic monophosphate in higher plants: Isolation and characterization of adenosine 3':5'-cyclic monophosphate from Kalanchoe and Agave. Biochem J (1977) 0.91

The distribution of sodium-potassium--activated adenosine triphosphatase in medulla and cortex of the kidney. J Clin Invest (1971) 0.91

Dissociation of cardiac inotropic and adenylate cyclast activating adrenoceptors. Br J Pharmacol (1974) 0.90

Adenylate cyclase activity in lymphocyte subcellular fractions. Characterization of non-nuclear adenylate cyclase. Biochem J (1977) 0.89

Formation of adenosine 5'-phosphorofluoridate and the assay of adenyl cyclase in barley seeds. Plant Physiol (1974) 0.88

Studies on sex-organ development. The hormonal regulation of steroidogenesis and adenosine 3':5'-cyclic monophosphate in embryonic-chick ovary. Biochem J (1977) 0.87

Adenylate cyclase in thymus-derived and bone marrow-derived lymphocytes from normal donors and patients with chronic lymphocytic leukemia. J Clin Invest (1979) 0.86

Solubilized myocardial adenylate cyclase. Restoration of histamine responsiveness by phosphatidylserine. J Clin Invest (1972) 0.86

Prostaglandins and their effects on human placental adenyl cyclase. J Clin Invest (1972) 0.84

Insulin release and cyclic AMP accumulation in response to glucose in pancreatic islets of fed and starved rats. J Clin Invest (1976) 0.84

Activation of membrane-bound adenylate cyclase by glucagon in Neurospora crassa. Proc Natl Acad Sci U S A (1972) 0.84

Hormonal interactions in the uterus: inhibition of isoproterenol-induced accumulation of adenosine 3':5'-cyclic monophosphate by oxytocin and prostaglandins. Proc Natl Acad Sci U S A (1972) 0.83

Brevibacterium liquefaciens adenylate cyclase and its in vivo stimulation by pyruvate. J Bacteriol (1975) 0.83

Studies on the enzymes involved in the biosynthesis of cyclo-tris (N-2,3-dihydroxybenzoyl-L-seryl) in Escherichia coli: kinetic properties of the L-serine-activating enzyme. J Bacteriol (1973) 0.83

Alkaline phosphatase. Possible induction by cyclic AMP after cholera enterotoxin administration. J Clin Invest (1973) 0.83

Evidence for oscillatory properties in the concentrations of adenosine 3':5'-cyclic onophosphate produced by cardiac sarcoplasmic reticulum. Biochem J (1970) 0.83

Regulation of dopamine stimulation of striatal adenylate cyclase by an endogenous Ca++ -binding protein. Proc Natl Acad Sci U S A (1976) 0.83

On the function of salivary myoepithelial cells. J Physiol (1972) 0.81

Demonstration of dopamine-sensitive adenylate cyclase in malignant neuroblastoma cells and change in sensitivity of adenylate cyclase to catecholamines in "differentiated" cells. Proc Natl Acad Sci U S A (1974) 0.81

Additional data on the function of hypothalamic histamine. Agents Actions (1981) 0.81

Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase. Biochem J (1970) 0.80

Articles by these authors

Enzymatic breakage and joining of deoxyribonucleic acid. VI. Further purification and properties of polynucleotide ligase from Escherichia coli infected with bacteriophage T4. J Biol Chem (1968) 7.09

Enzymatic breakage and joining of deoxyribonucleic acid, I. Repair of single-strand breaks in DNA by an enzyme system from Escherichia coli infected with T4 bacteriophage. Proc Natl Acad Sci U S A (1967) 5.98

Endonuclease IV (nfo) mutant of Escherichia coli. J Bacteriol (1986) 5.32

Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23

Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet (1997) 4.95

Transient accumulation of Okazaki fragments as a result of uracil incorporation into nascent DNA. Proc Natl Acad Sci U S A (1977) 4.83

Enzymatic breakage and joining of deoxyribonucleic acid. V. End group labeling and analysis of deoxyribonucleic acid containing single straned breaks. J Biol Chem (1968) 4.65

Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40

The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27

soxR, a locus governing a superoxide response regulon in Escherichia coli K-12. J Bacteriol (1990) 4.26

Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89

Two divergently transcribed genes, soxR and soxS, control a superoxide response regulon of Escherichia coli. J Bacteriol (1991) 3.81

Mutants of Escherichia coli with altered deoxyribonucleases. I. Isolation and characterization of mutants for exonuclease 3. J Mol Biol (1972) 3.65

Exonuclease III of Escherichia coli K-12, an AP endonuclease. Methods Enzymol (1980) 3.50

Endonuclease IV of Escherichia coli is induced by paraquat. Proc Natl Acad Sci U S A (1987) 3.20

Effects of a concurrent task on fixed-interval responding in humans. J Exp Anal Behav (1963) 3.05

Genetic mapping of xthA, the structural gene for exonuclease III in Escherichia coli K-12. J Bacteriol (1976) 3.01

Specific mutator effects of ung (uracil-DNA glycosylase) mutations in Escherichia coli. J Bacteriol (1982) 2.92

Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. Mol Pharmacol (1977) 2.90

Mutations simultaneously affecting endonuclease II and exonuclease III in Escherichia coli. Proc Natl Acad Sci U S A (1975) 2.89

Drowning mortality in Los Angeles County, 1976 to 1984. JAMA (1988) 2.89

Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J Pharmacol Exp Ther (1966) 2.75

Endonuclease III (nth) mutants of Escherichia coli. Proc Natl Acad Sci U S A (1985) 2.72

Two-stage induction of the soxRS (superoxide response) regulon of Escherichia coli. J Bacteriol (1992) 2.71

Further observations on overt "mediating" behavior and the discrimination of time. J Exp Anal Behav (1969) 2.64

Effects of psychotherapy with children and adolescents revisited: a meta-analysis of treatment outcome studies. Psychol Bull (1995) 2.59

Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol (1998) 2.58

A computer analysis of serial interactions in spaced responding. J Exp Anal Behav (1966) 2.34

Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother (2006) 2.31

Endonuclease II of Escherichia coli is exonuclease III. J Biol Chem (1976) 2.27

Role of exonuclease III in the base excision repair of uracil-containing DNA. J Bacteriol (1982) 2.23

Mass screening for mutants with altered DNases by microassay techniques. Methods Enzymol (1974) 2.18

Bridging the gap between laboratory and clinic in child and adolescent psychotherapy. J Consult Clin Psychol (1995) 2.17

Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. J Pharmacol Exp Ther (1979) 2.15

Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents. Adv Cyclic Nucleotide Res (1978) 2.12

The lab versus the clinic. Effects of child and adolescent psychotherapy. Am Psychol (1992) 2.11

Beta-receptor activity in aorta; variations with age and species. Circ Res (1970) 2.06

Escherichia coli mutants deficient in deoxyuridine triphosphatase. J Bacteriol (1978) 2.02

Pharmacological regulation of calmodulin. Ann N Y Acad Sci (1980) 2.02

Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain. Mol Pharmacol (1976) 2.02

The 5'-terminal dinucleotides of the separated strands of T7 bacteriophage deoxyribonucleic acid. J Mol Biol (1967) 2.01

Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc Natl Acad Sci U S A (1971) 2.00

Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology (2006) 1.98

SoxR, a [2Fe-2S] transcription factor, is active only in its oxidized form. Proc Natl Acad Sci U S A (1996) 1.94

Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther (1973) 1.90

Interrelationships of catecholamines with other endocrine systems. Pharmacol Rev (1966) 1.89

Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli. J Bacteriol (1988) 1.89

Behavioral responses to artificial food colors. Science (1980) 1.82

Regulation of the soxRS oxidative stress regulon. Reversible oxidation of the Fe-S centers of SoxR in vivo. J Biol Chem (1997) 1.77

Interactions of drugs with adrenergic neurons. Pharmacol Rev (1966) 1.76

A DNase for apurinic/apyrimidinic sites associated with exonuclease III of Hemophilus influenzae. J Biol Chem (1978) 1.75

Microassay of adenosine-3',5'-monophosphate (cyclic AMP) in brain and other tissues by the luciferin-luciferase system. J Neurochem (1971) 1.69

Prenatal phthalate exposure and reduced masculine play in boys. Int J Androl (2009) 1.69

Displacement of one drug by another from carrier or receptor sites. Proc R Soc Med (1965) 1.68

Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol (1990) 1.67

Establishment and maintenance of persistent infection by Sindbis virus in BHK cells. J Virol (1980) 1.66

Complementation between Sindbis viral RNAs produces infectious particles with a bipartite genome. Proc Natl Acad Sci U S A (1991) 1.64

Specificity of the binding of trifluoperazine to the calcium-dependent activator of phosphodiesterase and to a series of other calcium-binding proteins. Biochim Biophys Acta (1978) 1.59

The development of fixed-ratio performance under the influence of ribonucleic acid. J Exp Anal Behav (1972) 1.58

The microanalysis of fixed-interval responding. J Exp Anal Behav (1983) 1.58

Randomized clinical trial of lightweight composite mesh for Lichtenstein inguinal hernia repair. Br J Surg (2004) 1.56

A simple ultrasensitive method for the assay of cyclic AMP and cyclic GMP in tissues. Life Sci (1976) 1.56

Influence of drugs on behavior controlled by internal and external stimuli. J Pharmacol Exp Ther (1966) 1.56

The effects of inorganic ions on the storage and uptake of H3-norepinephrine by rat heart slices. J Pharmacol Exp Ther (1969) 1.55

Commercial talc and talcosis. Arch Environ Health (1967) 1.51

Familial contexts of adolescent ego development. Child Dev (1984) 1.48

Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships. J Pharmacol Exp Ther (1982) 1.47

Resistance to vecuronium in patients with cerebral palsy. Anesth Analg (1991) 1.44

Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications. Biochem Pharmacol (1982) 1.43

Ezymatic breakage and joining of deoxyribonucleic acid. VII. Properties of the enzyme-adenylate intermediate in the polynucleotide ligase reaction. J Biol Chem (1968) 1.42

Effectiveness of psychotherapy with children and adolescents: a meta-analysis for clinicians. J Consult Clin Psychol (1987) 1.42

Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones. Br J Pharmacol (1968) 1.38

Gametocytogenesis by malaria parasites in continuous culture. Nature (1980) 1.38

Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy. J Pharmacol Exp Ther (1987) 1.37

Giving up on child psychotherapy: who drops out? J Consult Clin Psychol (1987) 1.37

Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. J Med Genet (2009) 1.36

Overproduction and physical characterization of SoxR, a [2Fe-2S] protein that governs an oxidative response regulon in Escherichia coli. J Biol Chem (1995) 1.36

Oligonucleotide mapping studies of standard and defective Sindbis virus RNA. J Virol (1979) 1.36

Studies on the joining of DNA by polynucleotide ligase of phage T4. Cold Spring Harb Symp Quant Biol (1968) 1.35

Mutants of Escherichia coli with altered deoxyribonucleases. II. Isolation and characterization of mutants for exonuclease I. J Mol Biol (1974) 1.35

Parent reports of behavioral and emotional problems among children in Kenya, Thailand, and the United States. Child Dev (1993) 1.34

Human Observing Behavior after Signal Detection. J Exp Anal Behav (1960) 1.33

A microanalysis of drug effects on fixed-ratio performance in pigeons. J Pharmacol Exp Ther (1972) 1.33

Neurobehavioral toxicity as a basis for risk assessment. Trends Pharmacol Sci (1988) 1.32

A study of conidiation in Neurospora crassa. J Gen Microbiol (1966) 1.31

Evidence that blockade of adrenergic receptors causes overflow of norepinephrine in cats colon after nerve stimulation. J Pharmacol Exp Ther (1967) 1.30

Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1. Clin Pharmacol Ther (2010) 1.30

The role of brain serotonin in the mechanism of the central action of reserpine. J Pharmacol Exp Ther (1966) 1.30

dfp Gene of Escherichia coli K-12, a locus affecting DNA synthesis, codes for a flavoprotein. J Bacteriol (1985) 1.29

Defective interfering passages of Sindbis virus: chemical composition, biological activity, and mode of interference. J Virol (1973) 1.29

Defective interfering passages of Sindbis virus: nature of the defective virion RNA. J Virol (1976) 1.28

Compulsive sexual activity induced by p-chlorophenylalanine in normal and pinealectomized male rats. Science (1969) 1.28

Multiple mutant of Escherichia coli synthesizing virtually thymineless DNA during limited growth. J Bacteriol (1992) 1.28

Centrolobular hepatic necrosis related to covalent binding of metabolites of halogenated aromatic hydrocarbons. Exp Mol Pathol (1973) 1.27

Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum. Neuroscience (1993) 1.26

Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects. Environ Health Perspect (2001) 1.26

Preliminary mapping of mutations affecting exonuclease 3 in Escherichia coli K-12. J Bacteriol (1973) 1.26